Filter your results
- 4
- 4
- 4
- 1
- 2
- 1
- 4
- 3
- 3
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 2
- 3
- 3
- 3
- 3
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical modelsNature Communications, 2021, 12 (1), pp.6097. ⟨10.1038/s41467-021-26354-0⟩
Journal articles
pasteur-04098221v1
|
||
|
Rational design of HIV vaccines and microbicides: report of the EUROPRISE network annual conference 2010.Journal of Translational Medicine, 2011, 9 (1), pp.40. ⟨10.1186/1479-5876-9-40⟩
Journal articles
pasteur-00679111v1
|
||
|
Immunization with synthetic SARS-CoV-2 S glycoprotein virus-like particles protects macaques from infectionCell Reports Medicine, 2022, 3 (2), pp.100528. ⟨10.1016/j.xcrm.2022.100528⟩
Journal articles
hal-03621344v1
|
||
|
Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infectionCell, 2021, 184 (5), pp.1188-1200.e19. ⟨10.1016/j.cell.2021.01.035⟩
Journal articles
pasteur-04098199v1
|